NLCA Quarterly Report July 2019 to June 2022 (published July 2023)

NLCA Data Viewer Quarterly Report July 2023

The purpose of the National Lung Cancer Audit (NLCA) is to evaluate the patterns of care and outcomes for patients with lung cancer in England and Wales, and to support services to improve the quality of care for these patients.

This data viewer provides an overview of clinical process and outcomes for patients diagnosed with lung cancer in England between July 2019 and June 2022. Please see the NLCA Data tables for detailed results on the care received by patients diagnosed in Wales in 2020 and 2021.

In England, the NLCA receives information from the National Cancer Registration and Analysis Service (NCRAS). NCRAS collects patient-level data from all NHS acute providers on patients with cancer using a range of national data-feeds. This includes the Cancer Registration datasets and the Cancer Outcomes and Services Dataset (COSD). COSD data are submitted to the National Cancer Data Repository (NCDR) monthly via Multidisciplinary Team electronic data collection systems. The information held in the registration dataset is compiled from a number of sources, and clinical sign-off of data submitted to NCRAS is not mandated in England.

This NLCA report allocates patients to NHS organisations based on the “place of diagnosis” recorded within the dataset. It was not possible to allocate patients to NHS organisations based on the “site first seen”, as done in previous reports, because the RCRD did not contain this data item. The algorithm used previously to determine “site first seen” could not be used with the data supplied for this report, and we encourage NHS trusts to ensure the COSD field “place first seen” is completed to enable this approach in future.

 

 

Last updated: 6 October 2023, 10:20am